31 related articles for article (PubMed ID: 30605980)
1. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
[TBL] [Abstract][Full Text] [Related]
2.
Nasrollahzadeh D; Roshandel G; Delhomme TM; Avogbe PH; Foll M; Saidi F; Poustchi H; Sotoudeh M; Malekzadeh R; Brennan P; Mckay J; Hainaut P; Abedi-Ardekani B
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073316
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease.
Ma W; Zhang W; Liu H; Qian B; Lai R; Yao Z; Wang Y; Yan Y; Yuan Z
Cardiology; 2024; 149(2):155-162. PubMed ID: 37899036
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of multiple tumor markers for patients with esophageal carcinoma.
Zhang J; Zhu Z; Liu Y; Jin X; Xu Z; Yu Q; Li K
PLoS One; 2015; 10(2):e0116951. PubMed ID: 25693076
[TBL] [Abstract][Full Text] [Related]
5. Value of combined detection of serum carcino-embryonic antigen, carbohydrate antigen 19-9 and cyclooxygenase-2 in the diagnosis of colorectal cancer.
Yang W; Luo Y; Hu S; Li Y; Liu Q
Oncol Lett; 2018 Aug; 16(2):1551-1556. PubMed ID: 30008836
[TBL] [Abstract][Full Text] [Related]
6. Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma.
Huang Y; Liu F; Xu R; Zhou F; Yang W; He Y; Liu Z; Hou B; Liang L; Zhang L; Liu M; Pan Y; Liu Y; He Z; Ke Y
Front Oncol; 2023; 13():1263990. PubMed ID: 37810977
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of quantification of cell-free DNA for suspected gallbladder cancer.
Sakamoto K; Ogawa K; Tamura K; Honjo M; Sogabe K; Ito C; Iwata M; Sakamoto A; Shine M; Nishi Y; Uraoka M; Nagaoka T; Funamizu N; Takada Y
JGH Open; 2023 Nov; 7(11):748-754. PubMed ID: 38034057
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA.
Ghorbian S; Ardekani AM
Avicenna J Med Biotechnol; 2012 Jan; 4(1):3-13. PubMed ID: 23407878
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
10. Advances in application of CRISPR-Cas13a system.
Zhang Y; Li S; Li R; Qiu X; Fan T; Wang B; Zhang B; Zhang L
Front Cell Infect Microbiol; 2024; 14():1291557. PubMed ID: 38524179
[TBL] [Abstract][Full Text] [Related]
11. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
Yu D; An G; Xu L
Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical applications of circulating cell-free DNA in ovarian cancer patients.
Barbosa A; Peixoto A; Pinto P; Pinheiro M; Teixeira MR
Expert Rev Mol Med; 2018 Dec; 20():e6. PubMed ID: 30558693
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?
Yuan Z; Wang X; Geng X; Li Y; Mu J; Tan F; Xue Q; Gao S; He J
Cancer Commun (Lond); 2021 Jan; 41(1):3-15. PubMed ID: 33264481
[TBL] [Abstract][Full Text] [Related]
16. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
17. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]